Literature DB >> 36178610

Demographic, clinical and laboratory characteristics of adult-onset minimal change disease in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working Group.

Zeki Aydin1, Murvet Yilmaz2, Murat Sipahioglu3, Erkan Dervisoglu4, Nihal Aydemir5, Sami Uzun6, Zulal Istemihan7, Oktay Unsal8, Erhan Tatar9, Haci Bayram Berktas10, Arzu Ozdemir2, Abdullah Sumnu11, Gizem Kumru12, Hakki Cetinkaya13, Sinan Kazan14, Ismail Kocyigit3, Cenk Gokalp15, Baris Hasbal16, Ayse Serra Artan17, Ruya Ozelsancak18, Dilek Taymez19, Serap Yadigar20, Selma Alagoz21, Bilal Burcak Aslan22, Selcuk Yaylaci23, Jabrayil Jabrayilov24, Kenan Turgutalp25, Belda Dursun26, Garip Sahin27.   

Abstract

PURPOSE: In our study, diagnostic and demographic characteristics of patients diagnosed with minimal change disease (MCD) by biopsy, clinical and laboratory findings in our country were investigated.
METHODS: Data were obtained from the Turkish Society of Nephrology Glomerular Diseases (TSN-GOLD) Working Group database. Demographic characteristics, indications for biopsy, diagnosis of the glomerular diseases, comorbidities, laboratory and biopsy findings of all patients were recorded. The data presented are cross-sectional and includes application data for the biopsy period.
RESULTS: Of 3875 patients, 233 patients with MCD (median age 35.0 years) were included in the study, which constitutes 6.0% of the total glomerulonephritis database. Renal biopsy was performed in 196 (84.1%) patients due to nephrotic syndrome. Median serum creatinine was 0.7 (0.6-1.0) mg/dl, mean eGFR was 104 ± 33 ml/min/1.73 m2 and median proteinuria 6000 mg/day. The number of patients under the age of 40 years was 139 (59.7%) (Group A), and the number of patients aged 40 years and over was 94 (40.3%) (Group B). Compared to Group A, global sclerotic glomeruli (24 vs. 43, p < 0.001) interstitial inflammation (15 vs. 34, p < 0.001), interstitial fibrosis (20 vs. 31, p = 0.001, vascular changes (10 vs. 25, p < 0.001) and tubular atrophy (18 vs. 30, p < 0.001) were found to be significantly higher in Group B. There was no difference in immunofluorescent staining properties between the two groups.
CONCLUSION: Our data are generally compatible with the literature. Chronic histopathological changes were more common in patients aged 40 years and older than younger patients. Studies investigating the effects of these different features on renal survival are needed.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Minimal change disease; Nephrotic syndrome; Primary glomerular diseases

Year:  2022        PMID: 36178610     DOI: 10.1007/s11255-022-03382-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.266


  18 in total

Review 1.  Podocyte process effacement in vivo.

Authors:  Isao Shirato
Journal:  Microsc Res Tech       Date:  2002-05-15       Impact factor: 2.769

2.  Demographic and clinical characteristics of primary glomerular diseases in Turkey.

Authors:  Savas Ozturk; Abdullah Sumnu; Nurhan Seyahi; Mustafa Gullulu; Murat Sipahioglu; Serra Artan; Zerrin Bicik; Sim Kutlay; Mustafa Keles; Deren Oygar; Ali Riza Odabas; Mansur Kayatas; Belda Dursun; Hayriye Sayarlioglu; Sinan Trablus; Dilek Guven Taymez; Ali Abbas Ozdemir; Gulizar Manga Sahin; Bulent Altun; Alper Azak; Lutfullah Altintepe; Gultekin Suleymanlar; Mehmet Koc; Yilmaz Selcuk; Rumeyza Kazancioglu; Reha Erkoc; Meltem Gursu; Mehmet Kucuk; Selma Alagoz Akcaoglu; Abdulmecid Yıldız; Aydin Unal; Ozger Akarsu; Kenan Ates; Erdem Cankaya; Aydin Turkmen
Journal:  Int Urol Nephrol       Date:  2014-09-30       Impact factor: 2.370

3.  Adult-onset minimal change disease: the significance of histological chronic changes for clinical presentation and outcome.

Authors:  Gabriel Stefan; Ruxandra Busuioc; Simona Stancu; Madalina Hoinoiu; Adrian Zugravu; Nicoleta Petre; Gabriel Mircescu
Journal:  Clin Exp Nephrol       Date:  2020-10-22       Impact factor: 2.801

4.  Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis.

Authors:  A Fogo; E P Hawkins; P L Berry; A D Glick; M L Chiang; R C MacDonell; I Ichikawa
Journal:  Kidney Int       Date:  1990-07       Impact factor: 10.612

5.  Demographic, clinical and laboratory characteristics of rapidly progressive glomerulonephritis in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working Group.

Authors:  Zeki Aydin; Kultigin Turkmen; Fatih Dede; Emre Yasar; Savas Ozturk; Mehmet Aydin; Erhan Tatar; Garip Sahin; Gulizar Manga; Ozgur Oto; Abdullah Sumnu; Eray Eroglu; Tamer Dincer; Belda Dursun; Necmi Eren; Mustafa Sevinc; Fatma Betul Guzel; Serkan Yalin; Sim Kutlay; Suheyla Apaydin; Haci Bayram Berktas; Sinan Kazan; Hamad Dheir; Feyza Bora; Taner Basturk; Idris Sahin
Journal:  Clin Exp Nephrol       Date:  2020-10-11       Impact factor: 2.801

Review 6.  Minimal Change Disease.

Authors:  Marina Vivarelli; Laura Massella; Barbara Ruggiero; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-09       Impact factor: 8.237

7.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

Review 8.  Renal Biopsy in 2015--From Epidemiology to Evidence-Based Indications.

Authors:  Marco Fiorentino; Davide Bolignano; Vladimir Tesar; Anna Pisano; Wim Van Biesen; Graziella D'Arrigo; Giovanni Tripepi; Loreto Gesualdo
Journal:  Am J Nephrol       Date:  2016-02-05       Impact factor: 3.754

9.  IgM exacerbates glomerular disease progression in complement-induced glomerulopathy.

Authors:  Sarah E Panzer; Jennifer Laskowski; Brandon Renner; Liudmila Kulik; Danica Ljubanovic; Kendra M Huber; Weixiong Zhong; Matthew C Pickering; V Michael Holers; Joshua M Thurman
Journal:  Kidney Int       Date:  2015-05-06       Impact factor: 10.612

10.  Epidemiological features of primary glomerular disease in Turkey: a multicenter study by the Turkish Society of Nephrology Glomerular Diseases Working Group.

Authors:  Aydin Turkmen; Abdullah Sumnu; Egemen Cebeci; Halil Yazici; Necmi Eren; Nurhan Seyahi; Kamil Dilek; Fatih Dede; Ulver Derici; Abdulkadir Unsal; Garip Sahin; Murat Sipahioglu; Mahmut Gok; Erhan Tatar; Belda Dursun; Savas Sipahi; Murvet Yilmaz; Gultekin Suleymanlar; Sena Ulu; Ozkan Gungor; Sim Kutlay; Zerrin Bicik Bahcebasi; Idris Sahin; Ilhan Kurultak; Kultigin Turkmen; Zulfikar Yilmaz; Rumeyza Turan Kazancioglu; Caner Cavdar; Ferhan Candan; Zeki Aydin; Duriye Deren Oygar; Cuma Bulent Gul; Mustafa Arici; Saime Paydas; Dilek Guven Taymez; Mehmet Kucuk; Sinan Trablus; Kenan Turgutalp; Leyla Koc; Siren Sezer; Murat Duranay; Simge Bardak; Lutfullah Altintepe; Izzet Hakki Arikan; Alper Azak; Ali Riza Odabas; Gulizar Manga Sahin; Savas Ozturk
Journal:  BMC Nephrol       Date:  2020-11-14       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.